Today: 19 May 2026
Browse Category

NYSE:QSR 5 November 2025 - 5 February 2026

Is Dunkin Open on Christmas Day 2025? Dunkin Christmas Hours for Dec. 25, How to Check Your Store, and What’s on the Holiday Menu

Is Dunkin Open on Christmas Day 2025? Dunkin Christmas Hours for Dec. 25, How to Check Your Store, and What’s on the Holiday Menu

Many Dunkin’ locations plan to open on Christmas Day, Dec. 25, 2025, but hours vary by franchise. Some stores may open as early as 5 a.m. and close by 10 p.m., while others could reduce hours or close entirely. Christmas Eve hours are also shortened at many sites. Customers are urged to check the Dunkin’ app or store locator for exact local hours.
25 December 2025
·
Carl’s Jr. Drops $1 Meals Across SoCal as Shutdown Breaks Record—Who Qualifies, Where to Go, and What It Means for Fast‑Food Stocks

Carl’s Jr. Drops $1 Meals Across SoCal as Shutdown Breaks Record—Who Qualifies, Where to Go, and What It Means for Fast‑Food Stocks

The U.S. government shutdown reached Day 36, now the longest on record, after Senate talks failed overnight. Carl’s Jr. franchisee Akash Management LLC is offering $1 kids meals to federal workers, military families, and SNAP/EBT recipients at select Southern California locations during the shutdown. Courts ordered partial November SNAP funding, but delays and cuts are expected. L.A. County added $10 million to its food bank.
5 November 2025
······

Stock Market Today

  • Greek Stocks Outperform Nasdaq 100 Over Last 5 Years Amid Banking Sector Recovery
    May 19, 2026, 4:11 AM EDT. Greek equities, once devastated by the 2015 financial crisis and capital controls, have surged about 146% in the past five years, outperforming the Nasdaq 100's 116%. This recovery comes after a decade-high 47% non-performing loan ratio in Greek banks, resolved through the state-backed Hercules scheme and subsequent profitability restructuring. Major banks such as National Bank of Greece and Eurobank returned strong profits and shareholder dividends by 2025. The Athens Composite's rebound surpasses U.S. S&P 500 and Euro STOXX 50 returns, marking a powerful turnaround for a market once deemed broken.

Latest articles

HIVE Stock Up 29% While Nasdaq Moves Lower as Traders Eye AI Gigafactory

HIVE Stock Up 29% While Nasdaq Moves Lower as Traders Eye AI Gigafactory

19 May 2026
HIVE Digital Technologies closed at $3.46 on Nasdaq Monday, up 28.6%, and rose to $3.59 after hours following news of a planned 320 MW AI data center near Toronto targeting over 100,000 GPUs. The project is expected to cost C$3.5 billion and open in late 2027. Shares of other crypto miners fell as bitcoin traded near $77,142.
Ameren Holders Approve CEO Compensation, $14 Million Package Not Unanimous

Ameren Holders Approve CEO Compensation, $14 Million Package Not Unanimous

19 May 2026
Ameren shareholders approved executive pay, re-elected the full board, and ratified PwC as auditor. CEO Martin J. Lyons, Jr.’s 2025 compensation rose to $14.06 million, up from $9.73 million the previous year. The “say-on-pay” proposal received over 208 million votes in favor. Ameren shares last traded at $107.38, up $1.02.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 19.05.2026

19 May 2026
Warner Bros. Discovery shares traded at $27.10 on May 19, about 10% below some intrinsic value estimates but above a cited fair value of $18.17. The company reported $37.2 billion in annual revenue and a $1.7 billion loss. Analysts remain split on valuation amid merger talks with Paramount and ongoing regulatory uncertainty. Discounted cash flow models value the stock at $30.04.

Popular

Regeneron stock sinks after cancer trial miss prompts selloff

Regeneron stock sinks after cancer trial miss prompts selloff

19 May 2026
Regeneron Pharmaceuticals shares fell 9.8% to $629.68 Monday after its late-stage melanoma drug trial with fianlimab failed to meet the main goal. The study did not show a statistically significant benefit over Merck’s Keytruda. At least 10 brokerages cut price targets. The decline outpaced broader market losses, with the Nasdaq down 0.5%.
Go toTop